ACM
AMED

Azimuth Capital Management’s Amedisys AMED Stock Holding History

Azimuth Capital Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-30,070
Closed -$4.48M – 321
2021
Q3 		$4.48M Sell
30,070
-1,807
-6% -$376K 0.19% 149
2021
Q2 		$7.81M Buy
31,877
+850
+3% +$223K 0.34% 111
2021
Q1 		$8.22M Sell
31,027
-1,015
-3% -$286K 0.39% 96
2020
Q4 		$9.4M Buy
32,042
+162
+0.5% +$41.5K 0.47% 79
2020
Q3 		$7.54M Buy
31,880
+1,967
+7% +$447K 0.44% 80
2020
Q2 		$5.94M Buy
+29,913
New +$5.58M 0.38% 94

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Azimuth Capital Management's AMED Position: Q4 2021 in Review

Azimuth Capital Management sold out of Amedisys (AMED) in Q4 2021, closing a stake of 30,070 shares — an estimated $4.48M sold.

Azimuth Capital Management first reported a position in AMED in Q2 2020 and held it in 6 quarters. The position peaked at $9.4M in Q4 2020. 324 funds tracked by Wall St. Rank hold AMED as of Q4 2021.

  • Azimuth Capital Management reported no remaining Amedisys position as of Q4 2021 after selling out during the quarter.
  • Azimuth Capital Management sold 30,070 Amedisys shares in Q4 2021, an estimated $4.48M.
  • Azimuth Capital Management first reported a position in Amedisys in Q2 2020 and held it in 6 quarters.
  • Azimuth Capital Management's Amedisys position peaked at $9.4M in Q4 2020.
  • 324 funds tracked by Wall St. Rank held Amedisys as of Q4 2021.

Based on Azimuth Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.